Correlation Between Alpha Cognition and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alpha Cognition and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alpha Cognition and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alpha Cognition and Eupraxia Pharmaceuticals, you can compare the effects of market volatilities on Alpha Cognition and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alpha Cognition with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alpha Cognition and Eupraxia Pharmaceuticals.
Diversification Opportunities for Alpha Cognition and Eupraxia Pharmaceuticals
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alpha and Eupraxia is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Alpha Cognition and Eupraxia Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Alpha Cognition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alpha Cognition are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Alpha Cognition i.e., Alpha Cognition and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alpha Cognition and Eupraxia Pharmaceuticals
Assuming the 90 days horizon Alpha Cognition is expected to generate 12.91 times more return on investment than Eupraxia Pharmaceuticals. However, Alpha Cognition is 12.91 times more volatile than Eupraxia Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Eupraxia Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 1,318 in Alpha Cognition on November 5, 2024 and sell it today you would lose (677.00) from holding Alpha Cognition or give up 51.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 33.33% |
| Values | Daily Returns |
Alpha Cognition vs. Eupraxia Pharmaceuticals
Performance |
| Timeline |
| Alpha Cognition |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Alpha Cognition and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alpha Cognition and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Alpha Cognition and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alpha Cognition position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.| Alpha Cognition vs. Akeso, Inc | Alpha Cognition vs. Avax Techs | Alpha Cognition vs. Transgene SA | Alpha Cognition vs. Fennec Pharmaceuticals |
| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |